cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2005; 46:101-105, doi:10.1016/j.jacc.2005.03.045
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petersen, S. E.
Right arrow Articles by Neubauer, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petersen, S. E.
Right arrow Articles by Neubauer, S.

CLINICAL RESEARCH: CLINICAL INSIGHTS FROM CARDIAC IMAGING

Left Ventricular Non-Compaction

Insights From Cardiovascular Magnetic Resonance Imaging

Steffen E. Petersen, MD*,{dagger}, Joseph B. Selvanayagam, MBBS, FRACP*,{dagger}, Frank Wiesmann, MD*,{dagger}, Matthew D. Robson, PhD*,{dagger}, Jane M. Francis, DCRR, DNM*,{dagger}, Robert H. Anderson, MD, FRCPath{ddagger}, Hugh Watkins, MD, PhD, FRCP{dagger} and Stefan Neubauer, MD, FRCP*,{dagger},*

* University of Oxford Centre for Clinical Magnetic Resonance Research, Oxford, United Kingdom
{dagger} Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, United Kingdom
{ddagger} Cardiac Unit, Institute of Child Health, University College London, London, United Kingdom

Manuscript received October 25, 2004; revised manuscript received February 9, 2005, accepted March 10, 2005.

* Reprint requests and correspondence: Dr. Stefan Neubauer, University of Oxford Centre for Clinical Magnetic Resonance Research, University Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom (Email: stefan.neubauer{at}cardiovascular-medicine.ox.ac.uk).


    Abstract
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
OBJECTIVES: We aimed to test the diagnostic accuracy of cardiovascular magnetic resonance (CMR) imaging in distinguishing pathological left ventricular non-compaction (LVNC) from lesser degrees of trabecular layering seen in healthy volunteers and, in those with cardiomyopathies and concentric left ventricular hypertrophy, potential differential diagnoses. We hypothesized that pathological trabeculation could be distinguished by determining the ratio of non-compacted to compacted myocardium (NC/C ratio).

BACKGROUND: Left ventricular non-compaction is characterized by a non-compacted myocardial layer in the left ventricle. Cardiovascular magnetic resonance images this layer with unprecedented quality, particularly in the ventricular apex, where echocardiography has inherent difficulties.

METHODS: We analyzed magnetic resonance cine images, using the 17-segment model in 45 healthy volunteers, 25 athletes, 39 patients with hypertrophic cardiomyopathy and 14 with dilated cardiomyopathy, 17 with hypertensive heart disease, and 30 with aortic stenosis, as well as images from 7 patients previously diagnosed with LVNC whose diagnoses were supported by additional features.

RESULTS: Areas of non-compaction were common and occurred more frequently in all groups studied in apical and lateral, rather than in basal or septal, segments. A NC/C ratio of >2.3 in diastole distinguished pathological non-compaction, with values for sensitivity, specificity, and positive and negative predictions of 86%, 99%, 75%, and 99%, respectively.

CONCLUSIONS: Left ventricular non-compaction is diagnosed accurately with CMR using the NC/C ratio in diastole.

Abbreviations and Acronyms
  CMR = cardiovascular magnetic resonance
  DCM = dilated cardiomyopathy
  LV = left ventricle/ventricular
  LVNC = left ventricular non-compaction
  NC/C ratio = ratio of non-compacted to compacted myocardium


Left ventricular non-compaction (LVNC) is characterized by the presence of an extensive non-compacted myocardial layer lining the cavity of the left ventricle (LV) and potentially leads to cardiac failure, thromboembolism, and malignant arrhythmias (1,2). It can be associated with neuromuscular disorders (3) and can co-exist with other cardiac malformations (2). On the basis of echocardiographic studies, its prevalence has been estimated at 0.05% in the general population (1), and the finding of a ratio of >2.0 between the thickness of the non-compacted and compacted myocardial layers in systole is considered diagnostic (4). Echocardiography, however, poses inherent problems in assessing the LV apex, known to be the most commonly non-compacted area (5).

Because high-resolution imaging techniques, such as multi-detector computed tomography, have shown the frequent presence of pronounced trabeculae within healthy myocardium (6), a similar finding may be expected in both healthy and diseased hearts with cardiovascular magnetic resonance (CMR), which is increasingly used in clinical practice. Accordingly, it is necessary to establish specific CMR criteria for the diagnosis of pathological non-compaction. To this end, we examined healthy volunteers as well as patients with potential differential diagnoses for LVNC. Findings from this group were compared with those of unequivocal LVNC cases whose diagnoses were supported by other clinical features.


    Methods
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
The study was approved by our institutional ethics committee. Each participant gave written informed consent.

Participants.   We enrolled seven patients with clinical diagnoses of LVNC on the basis of either echocardiographic or CMR documentation of a distinct two-layered appearance of trabeculated and compacted myocardium. An arbitrary threshold for the degree of non-compaction was not applied so as not to exclude patients with a partial expression of the disease (7). The imaging findings had to be accompanied by one of the following to increase the pre-test probability for this diagnosis: documentation of a similar appearance in first-degree relatives suggestive of autosomal dominant transmission, associated neuromuscular disorders, or complications, such as systemic embolization and regional wall motion abnormalities (Table 1). The remaining subjects were healthy volunteers without a history of cardiovascular symptoms or risk factors or drawn from groups given a potential differential diagnosis for LVNC: 25 competitive athletes, 14 patients with dilated cardiomyopathy (DCM), 39 with hypertrophic cardiomyopathy, 17 with LV hypertrophy secondary to hypertension, and 30 with aortic stenosis.


View this table:
[in this window]
[in a new window]
 
Table 1. Characteristics of Patients Diagnosed With LVNC
 
High-level competitive athletes with an average of 19 ± 7 h of training per week were recruited. Patients with hypertrophic cardiomyopathy were diagnosed on the basis of family history and standard electrocardiographic and echocardiographic criteria in the absence of a secondary cause for cardiac hypertrophy. The diagnosis of DCM was made on the basis of impaired global LV function, with an ejection fraction of <40% on echocardiography, and exclusion of other causes of LV dysfunction. Patients with hypertension and patients with aortic stenosis were enrolled if they showed an end-diastolic wall thickness of >13 mm on echocardiography.

Magnetic resonance imaging.   All CMR exams were performed at 1.5-T (Sonata, Siemens Medical Solutions, Erlangen, Germany). Steady-state free precession cine images (echo time/repetition time 1.5/3.0 ms, flip angle 60°) were acquired in three long-axis views (i.e., horizontal and vertical long-axis and LV outflow tract), planned on short-axis pilots at 60° angles to each other to visualize all 17 segments according to the American Heart Association recommendation (8).

Data analysis.   Cine images were analyzed with CMR tools (Imperial College, London, United Kingdom); the observer was blinded to the diagnosis. The distribution of non-compaction was assessed by qualitative analysis of all 17 segments for presence or absence of any degree of non-compaction (i.e., for a distinct two-layered appearance of trabeculated and compacted myocardium). A segment was regarded as non-compacted if the visual appearance clearly suggested the presence of two myocardial layers with different degrees of tissue compaction. In each of the three diastolic long-axis views, the segment with the most pronounced trabeculations was chosen for measurement of the thickness of the non-compacted and the compacted myocardium perpendicular to the compacted myocardium. The ratio of non-compacted to compacted myocardium (NC/C ratio) in diastole was calculated for each of the three long-axis views, and only the maximal ratio was then used for analysis. The apex (segment 17) was excluded from the measurements, because the compacted myocardium is generally thinner in this area and inclusion would have led to artificially high ratios.

Statistical analysis.   All data are presented as mean ± standard deviation. Nominal data were tested using the chi-square test. Continuous data were analyzed using analysis of variance with post-hoc Bonferroni analysis to establish differences between LVNC and the six remaining groups individually. A p value of <0.05 (after Bonferroni adjustment) was considered statistically significant. We used receiver operating characteristics to generate cut-off values for optimized sensitivity and specificity to distinguish LVNC from all other groups of subjects.


    Results
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Non-compaction was more common in the apical segments of the healthy volunteers, being found in 91% of subjects, as compared with the mid-cavity levels (78%) and the basal segments (21%) (Fig. 1). Non-compaction was most common in the anterior segment, becoming less frequent in successive segments as viewed in a clockwise direction. Similar patterns of distribution were seen in hearts of the patients with confirmed LVNC and in those of the other groups (Fig. 1). Overall, patients with pathological non-compaction had involvement of significantly (p < 0.01) more myocardial segments (10 ± 3 segments) than did healthy volunteers (6 ± 3 segments), athletes (6 ± 4 segments), patients with hypertrophic (5 ± 4 segments) and dilated cardiomyopathy (7 ± 3 segments), and patients with LV hypertrophy secondary to hypertension (4 ± 4 segments), and patients with aortic stenosis (6 ± 4 segments).



View larger version (36K):
[in this window]
[in a new window]
 
Figure 1 Distribution of non-compaction. The bars represent the percentage of subjects in each group with non-compaction in given segments. The pattern of distribution of non-compaction does not separate the groups.

 
The end-diastolic NC/C ratio was, on average, at least 60% greater in patients with LVNC (3.0 ± 1.5) compared with all other groups (p < 0.01 for all) (Fig. 2). Receiver operating characteristics analysis identified the end-diastolic NC/C ratio as a valuable parameter to distinguish pathological non-compaction from the lesser degrees of non-compaction encountered in healthy, dilated, and hypertrophied hearts. A NC/C ratio of >2.3 in diastole distinguished pathological non-compaction, with values for sensitivity, specificity, positive, and negative predictions of 86%, 99%, 75%, and 99%, respectively.



View larger version (11K):
[in this window]
[in a new window]
 
Figure 2 Ratio of the end-diastolic thickness of the non-compacted and compacted layers of the myocardium (NC/C ratio). Data are presented as means (squares) and 95% confidence interval (whiskers). **p < 0.01. DCM = dilated cardiomyopathy; HCM = hypertrophic cardiomyopathy; LVNC = left ventricular non-compaction.

 

    Discussion
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
We found that the degree of non-compaction of the LV was far more frequent in healthy, dilated, and hypertrophied hearts than previously reported in cardiac imaging studies; presumably this is a manifestation of the increased sensitivity of CMR. Nevertheless, we have shown that the ratio between the trabecular and compact layers of the myocardium as measured by CMR in diastole is accurate in detecting pathological LVNC.

The segmental distribution of non-compaction in healthy, dilated, and hypertrophied hearts was similar to that found in the patients with confirmed LVNC; however, the ratio between the myocardial thicknesses was at least 60% greater in those with LVNC. Therefore, we are unable to lend support to the recent suggestion that the segmental distribution can be used to clarify the diagnosis of LVNC (2,4).

The trabecular layer of the developing ventricular walls is known to compact during its development from base to apex, from epicardium to endocardium, and from the septal to the lateral wall (9). Although the underlying pathophysiologic mechanisms for lack of such compaction remain unresolved, varying degrees of arrest of this normal embryologic process (4) provide an attractive explanation for the typical pattern of distribution seen in all our subjects. Almost 70% of autopsied healthy hearts are reported to show some degree of non-compaction (10), a finding endorsed by the prevalence observed in our study and probably one with no prognostic relevance. Partial expression of pathological LVNC is illustrated by one patient (Patient #2; Table 1, Fig. 3) who has only mild anatomical non-compaction, but supporting evidence for this diagnosis. This phenomenon is typical of autosomal dominant conditions and has recently been reported in large families with autosomal dominant LVNC (7).



View larger version (135K):
[in this window]
[in a new window]
 
Figure 3 The autosomal dominant pattern of inheritance in a family with pathological left ventricular non-compaction. Diastolic horizontal long-axis views of parents (I:1 father and I:2 mother) and children (II:1, II.2) show variable degrees of non-compaction (black dotted arrows) in I:1 (Patient #3; Table1), II:1 (Patient #2; Table 1), and II:2 (Patient #1; Table 1). Patient II:1 likely illustrates partial expression of pathological non-compaction, because her ratio of end-diastolic thicknesses is <2.3 (1.1).

 
Previous case studies using CMR imaging have usually considered echocardiographic criteria to represent the gold standard for diagnosis. One small study, mainly using older gradient echo sequences, suggested echocardiography to be superior to CMR at that time (11). Advances in CMR have resulted in superior image quality. We used diastolic steady-state free precession cine frames to determine the ratio of thickness of the trabecular and compact layers, the trabeculations being more easily identified by CMR in the relaxed heart. The diastolic ratio of >2.3 showed high diagnostic accuracy for distinguishing pathological LVNC from the degrees of non-compaction observed in healthy, dilated, and hypertrophied hearts. This slightly higher cut-off value reflects that the measurement obtained with CMR is taken in diastole, whereas the echocardiographic values are taken in systole (cut-off value of 2.0) (4).

Study limitations.   The main limitation of our study is the relatively small number of patients with features of LVNC in whom the diagnosis could be confirmed by the presence of other abnormalities. Isolated echocardiographic or CMR evidence of marked non-compaction was intentionally not considered sufficient for inclusion so as to avoid circular reasoning.

Conclusions.   We have shown that, on the basis of the ratio of end-diastolic thickness of the non-compacted and compacted layers of the myocardium, CMR imaging is accurate when diagnosing pathological LVNC. We propose that measurements are best made in diastole and that the cut-off values should be different from those used in echocardiography. Our findings support the clinical use of CMR in diagnosing LVNC, especially for those patients with poor echocardiographic windows.


    Acknowledgments
 
The authors thank Drs. Saul Myerson, Michaela Scheuermann-Freestone, Monique Robinson, and Barbara Casadei for help in recruiting.


    Footnotes
 
This study was supported by grants from the German Academic Exchange Service (Dr. Petersen), the British Heart Foundation (Drs. Neubauer, Watkins, and Anderson) and the Wellcome Trust (Drs. Wiesmann, Selvanayagam, Neubauer, and Watkins).


    References
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 

  1. Ritter M, Oechslin E, Sutsch G, Attenhofer C, Schneider J, Jenni R. Isolated noncompaction of the myocardium in adults Mayo Clin Proc 1997;72:26-31.[ISI][Medline]
  2. Oechslin EN, Attenhofer Jost CH, Rojas JR, Kaufmann PA, Jenni R. Long-term follow-up of 34 adults with isolated left ventricular noncompactiona distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 2000;36:493-500.[Abstract/Free Full Text]
  3. Stollberger C, Finsterer J, Blazek G. Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders Am J Cardiol 2002;90:899-902.[CrossRef][ISI][Medline]
  4. Jenni R, Oechslin E, Schneider J, Jost CA, Kaufmann PA. Echocardiographic and pathoanatomical characteristics of pathological non-compaction, as a distinct cardiomyopathy Heart 2001;86:666-671.[Abstract/Free Full Text]
  5. Moon JC, Fisher NG, McKenna WJ, Pennell DJ. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography Heart 2004;90:645-649.[Abstract/Free Full Text]
  6. Axel L. Papillary muscles do not attach directly to the solid heart wall Circulation 2004;109:3145-3148.[Abstract/Free Full Text]
  7. Sasse-Klaassen S, Probst S, Gerull B, et al. Novel gene locus for autosomal dominant left ventricular noncompaction maps to chromosome 11p15 Circulation 2004;109:2720-2723.[Abstract/Free Full Text]
  8. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the hearta statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-542.[Free Full Text]
  9. Sedmera D, Pexieder T, Vuillemin M, Thompson RP, Anderson RH. Developmental patterning of the myocardium Anat Rec 2000;258:319-337.[CrossRef][Medline]
  10. Boyd MT, Seward JB, Tajik AJ, Edwards WD. Frequency and location of prominent left ventricular trabeculations at autopsy in 474 normal human heartsimplications for evaluation of mural thrombi by two-dimensional echocardiography. J Am Coll Cardiol 1987;9:323-326.[Abstract]
  11. Weiss F, Habermann CR, Lilje C, et al. [MRI in the diagnosis of non-compacted ventricular myocardium (NCVM) compared to echocardiography] Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2003;175:1214-1219.[Medline]



This article has been cited by other articles:


Home page
CirculationHome page
R. H. Bagur, M. Lederlin, M. Montaudon, V. Latrabe, O. Corneloup, X. Iriart, and F. Laurent
Ebstein Anomaly Associated With Left Ventricular Noncompaction
Circulation, October 14, 2008; 118(16): e662 - e664.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Ashikaga, B. A. Coppola, K. G. Yamazaki, F. J. Villarreal, J. H. Omens, and J. W. Covell
Changes in regional myocardial volume during the cardiac cycle: implications for transmural blood flow and cardiac structure
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H610 - H618.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62.
[Full Text] [PDF]


Home page
CirculationHome page
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Circulation, May 27, 2008; 117(21): e350 - e408.
[Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
O. Tufekcioglu, D. Aras, A. Yildiz, S. Topaloglu, and O. Maden
Myocardial contraction properties along the long and short axes of the left ventricle in isolated left ventricular non-compaction: pulsed tissue Doppler echocardiography
Eur J Echocardiogr, May 1, 2008; 9(3): 344 - 350.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T. Germans, A. A.M. Wilde, and A. C. van Rossum
Non-compaction: a distinct cardiomyopathy or non-specific morphological trait?
Eur. Heart J., April 1, 2008; 29(7): 949 - 950.
[Full Text] [PDF]


Home page
Eur Heart JHome page
D. Dooijes
Non-compaction: a distinct cardiomyopathy or non-specific morphological trait?: reply
Eur. Heart J., April 1, 2008; 29(7): 950 - 951.
[Full Text] [PDF]


Home page
HeartHome page
T. Germans and A. C van Rossum
The use of cardiac magnetic resonance imaging to determine the aetiology of left ventricular disease and cardiomyopathy
Heart, April 1, 2008; 94(4): 510 - 518.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
J. D. Dodd and R. C. Cury
Reply
Am. J. Roentgenol., April 1, 2008; 190(4): W274 - W274.
[Full Text] [PDF]


Home page
Eur Heart JHome page
S. K. Kohli, A. A. Pantazis, J. S. Shah, B. Adeyemi, G. Jackson, W. J. McKenna, S. Sharma, and P. M. Elliott
Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria?
Eur. Heart J., January 1, 2008; 29(1): 89 - 95.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. H. Anderson
Ventricular non-compaction a frequently ignored finding?
Eur. Heart J., January 1, 2008; 29(1): 10 - 11.
[Full Text] [PDF]


Home page
Eur Heart JHome page
T. D. Karamitsos, J. R. Arnold, S. Neubauer, and S. E. Petersen
Redefining cardiomyopathies: the role of cardiovascular magnetic resonance imaging
Eur. Heart J., December 2, 2007; 28(24): 3094 - 3095.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
J. D. Dodd, G. Holmvang, U. Hoffmann, M. Ferencik, S. Abbara, T. J. Brady, and R. C. Cury
Quantification of Left Ventricular Noncompaction and Trabecular Delayed Hyperenhancement with Cardiac MRI: Correlation with Clinical Severity
Am. J. Roentgenol., October 1, 2007; 189(4): 974 - 980.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. Pastor, J. I. Aramendi, M. Luis, R. Voces, M. A. Rodriguez, and J. M. Galdeano
Isolated Pseudohypoplasia of the Right Ventricle
Ann. Thorac. Surg., August 1, 2007; 84(2): 668 - 670.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R Jenni, E N Oechslin, and B van der Loo
Isolated ventricular non-compaction of the myocardium in adults
Heart, January 1, 2007; 93(1): 11 - 15.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Lilje, V. Razek, J. J. Joyce, T. Rau, B. F. Finckh, F. Weiss, C. R. Habermann, J. C. Rice, and J. Weil
Complications of non-compaction of the left ventricular myocardium in a paediatric population: a prospective study
Eur. Heart J., August 1, 2006; 27(15): 1855 - 1860.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Stollberger and J. Finsterer
Left Ventricular Noncompaction, Cardiac Magnetic Resonance Imaging, and Neuromuscular Disorders
J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1233 - 1234.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. E. Petersen, J. B. Selvanayagam, F. Wiesmann, M. D. Robson, J. M. Francis, R. H. Anderson, H. Watkins, and S. Neubauer
Reply
J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1234 - 1235.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petersen, S. E.
Right arrow Articles by Neubauer, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petersen, S. E.
Right arrow Articles by Neubauer, S.

 
  cardiology careers collections past issues search home